Retained capacity of glucose-mediated insulin secretion in patients with type 2 diabetes mellitus inversely correlates with the duration of diabetes.
Kaku
Kohei
K
Department of Medicine, Endocrine & Diabetes Division, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. kka@med.kawasaki-m.ac.jp
Kawasaki
Fumiko
F
Kanda
Yukiko
Y
Matsuda
Masafumi
M
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D015992:Body Mass Index; D002908:Chronic Disease; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D004334:Drug Administration Schedule; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D005951:Glucose Tolerance Test / Q000379:methods; D005905:Glyburide / Q000494:pharmacology / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000737:chemistry; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D007564:Japan; D008875:Middle Aged; D013997:Time Factors
D001786:Blood Glucose; D005947:Glucose; D005905:Glyburide; D006442:Glycated Hemoglobin; D007328:Insulin